米氮平

应用P300评估脑卒中后抑郁患者米氮平治疗前后认知功能的变化

Evaluation of cognitive function in post-stroke depressive patients treated with mirtazapine by using P300

方法：67例同时符合抑郁症与焦虑障碍诊断标准的门诊患者，分别随机给予口服米氮平联合乌灵胶囊（简称A组）和单一口服米氮平（简称B组）。

Methods : 67 cases according to the diagnostic standard both for depression and anxiety disorder were administered randomly mirtazapine united with Wuling capsule ( briefly group A ) or mirtazapine alone ( briefly group B ) .

结论①在阿米替林等药物治疗FS基础上，联合小剂量米氮平及白芍总苷胶囊能明显提高疗效，且较安全。

Conclusions ① The efficacy will be obviously improved and safer by the basic treatment of fibromyalgia syndrome ( FS ) employing amitriptyline , by adding low dose mirtazpine .

新型抗真菌药物caspofungin结论：米氮平是一种安全、有效的新型抗抑郁药物。

A new class of antifungal agent : caspofungin CONCLUSION : Mirtazapine is an effective , well tolerated and rapidly responded new antidepressant .

目的比较阿米替林基础治疗，加用米氮平，加用白芍总苷胶囊及联合用药4组对纤维肌痛综合征（FS）的疗效。

Objective To compare the efficacy between basic treatment , amitriptyline , and basic treatment combined with mirtazapine and total glucosides of paeonia ( TGP ) capsule in 4 groups of patients with fibromyalgia syndrome ( FS ) .

米氮平与阿普唑仑治疗慢性失眠症的临床疗效比较

Comparison of Therapeutic Effects between Mirtazapine and Alprazolam on Chronic Insomnia

米氮平与氟西汀治疗抑郁症的最小成本分析

Mirtazapine and Fluoxetine in Treating Depression : Cost - minimization Analysis

米氮平与西酞普兰治疗躯体形式障碍的对照研究

Comparative Study of Mirtazapine and Citalopram in Treatment of Somatoform Disorder

米氮平与氟西丁治疗老年抑郁症患者的对照研究

Comparative Study of Mirtazapine and Fluoxetine in the Treatment of Senile Depression

文拉法辛与米氮平治疗抑郁症的临床比较分析

Clinical comparative analysis of Venlafaxine versus Mirtazapine in the treatment of depression

目的探讨米氮平治疗抑郁症的疗效与安全性。

Objective To explore efficacy and side effects of mirtazapine .

米氮平治疗精神分裂症后抑郁的临床研究

The Study of Mirtazapine in the Treatment of Patients with Post-schizophrenic Depression

米氮平在鼠肝微粒体中的体外代谢研究

Research of metabolism of antidepressant mirtazapine on mice liver microsome in vitro

米氮平联合匹维溴胺治疗肠易激综合征的效果及其对神经肽Y水平的影响

Effect of Mirtazapine on Irritable Bowel Syndrome and Changes of Neuropeptide-Y Level

结论米氮平是一种安全、有效的新型抗抑郁药物，起效较快。

Conclusion Mirtazapine is a safe , effective antidepressant with rapid response .

米氮平治疗抑郁症及焦虑症的临床疗效比较

Comparisons of clinical efficacy of mirtazapine in the treatment of depression and anxiety

米氮平治疗伴有焦虑的抑郁症

Mirtazapine in the Treatment of Depression Associated with Anxiety

结论：米氮平对伴有焦虑症状的抑郁症有良好的疗效。

Conclusion : mirtazapine had good effectiveness in the depressed patients with anxiety symptoms .

米氮平与氟西汀治疗脑卒中后抑郁焦虑障碍对照研究

A comparative study of mirtazapine and fluoxetine in the treatment of post-stroke depression-anxiety disorder

米氮平与氯丙米嗪治疗抑郁症伴有焦虑的临床评价

Clinical Evaluation of Mirtazapine and Clomipramine for the Treatment of Depressive Disorder Associated with Anxiety

米氮平与氟西汀治疗以失眠为主诉的老年抑郁症患者的对照研究

A Comparative Study of Mirtazapine and Fluoxetine in Treatment of Elderly Depressive Patients with Insomnia

目的：合成抗抑郁药米氮平。

Objective : To synthesize antidepressant mirtazapine .

米氮平对阿片类稽延性戒断症状患者焦虑情绪和睡眠障碍的干预

Intervention of remeron for anxious emotion and dyssomnia in patients with opium protracted abstinence symptom

LC-MS/MS同时测定人血浆中氯氮平、奥氮平和米氮平

Simultaneous Determination of Clozapine , Olanzapine and Mirtazapine in Human Plasma by LC-MS / MS

米氮平联合乌灵胶囊及单一米氮平治疗抑郁和焦虑障碍共病的疗效对照

Comparison of Mirtazapine United With Wuling Capsule and Mirtazapine Alone for Depression and Anxiety Comorbidity

结果米氮平治疗抑郁症有效率87.7%，显效率61%，未见严重不良反应。

Results The efficacy rate of mirtazapine was 87.8 % in which 61 % were improved markedly .

方法：将60例伴抑郁的心血管神经官能症患者随机分为米氮平组和氟西汀组，进行为期42天的治疗观察。

Methods : 60 patients with cardiovascular neurosis with depression were randomly treated with mirtazapine or fluoxetine .

结论：抑郁症患者对米氮平依从性高主要是因疗效好，不良反应轻。

Conclusion : Mirtazapine has better efficacy and less adverse effects in the maintenance treatment of depression .

药物不良反应发生率米氮平明显低于阿米替林。结论：米氮平治疗抑郁症有效，未发现严重不良反应。

Conclusion : Mirtazaine is effective in treatment of depression and no severe adverse reactions were observed .

米氮平联合认知疗法治疗脑卒中后抑郁的疗效观察

The observation on the effect of mirtazapine combined with cognitive therapy in the treatment of post-stroke depression